TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed Mr. Camilo Villalba as Chief Executive Officer of the Company. Mr. Villalba, who is a co-founder of Blueberries and currently serves as Chief Operating Officer, will lead the Company's next phase of operational development, with initial exports expected during the first half of 2020. Dr. Patricio Stocker will continue to support Blueberries as a Senior Strategic Consultant focused on expanding the Company's international cannabis sales and other strategic initiatives.